Tamoxifen malabsorption after Roux-en-Y gastric bypass surgery: case series and review of the literature

Pharmacotherapy
Shannon M WillsDavid Decker

Abstract

Roux-en-Y gastric bypass is a gastric reduction duodenal switch with a combination of restrictive and malabsorptive procedures. It is the most common gastric bypass procedure performed in the United States. Malabsorption causing nutritional deficiencies does occur, yet a PubMed literature search (1955-2009) returned no reports of malabsorption of anticancer agents after gastric bypass. To our knowledge, this is the first report of three cases of malabsorption of the anticancer agent tamoxifen after this procedure. The first patient was a 58-year-old woman who underwent Roux-en-Y bypass for morbid obesity. Two years later, she developed estrogen receptor-positive ductal carcinoma in situ of the breast, underwent lumpectomy and irradiation, and tamoxifen was started. Two years after that, she presented with concerns of potential malabsorption of the drug. Her plasma tamoxifen level was 28 ng/ml, which was below the lower limit of the therapeutic range (77-274 ng/ml for 10-30-mg/day regimens). The second patient was a 51-year-old woman who sought medical advice on risk reduction for breast cancer after receiving a diagnosis of atypical ductal hyperplasia of the breast. She also had a history of morbid obesity and underwent Roux-en...Continue Reading

Citations

Jun 11, 2014·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Inbal GolombAndrei Keidar
Sep 25, 2012·Expert Opinion on Drug Metabolism & Toxicology·Dion R BrocksRaj S Padwal
Nov 21, 2012·Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons·Michael MiloroSalvatore L Ruggiero
Jan 25, 2011·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·James L RoerigLi Cao
May 15, 2013·Journal of Clinical Pharmacology·Judith Aron-WisnewskyMarion Buyse
Jul 15, 2015·Hormone Molecular Biology and Clinical Investigation·Lore LapeireOlivier De Wever
Jun 24, 2016·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Carmil AzranArik Dahan
Oct 9, 2020·Journal of Clinical Pharmacology·Alexander A BoucherLori Luchtman-Jones
May 16, 2021·British Journal of Clinical Pharmacology·Jurjen S KingmaCatherijne A J Knibbe
Jul 17, 2021·European Journal of Clinical Pharmacology·Susanna M WallerstedtMagnus A B Axelsson
May 4, 2020·Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery·Saber GhiassiUNKNOWN American Society for Metabolic and Bariatric Surgery Clinical Issues Committee

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.